Wide Ranks

CLYM

Climb Bio, Inc.

3.22

Top Statistics
Market Cap 216 M Forward PE 0.0000 Revenue Growth 0.00 %
Current Ratio 57.73 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA Enterprise / Revenue Price To Sales Trailing12 Months
Profitability
Profit Margins 0.00 % Operating Margins
Balance Sheet
Total Cash 193 M Total Cash Per Share 2.88 Total Debt 58000
Total Debt To Equity 0.0270 Current Ratio 57.73 Book Value Per Share 3.25
All Measures
Short Ratio 1473.00 % Message Board Id finmb_603195850 Shares Short Prior Month 4 M
Return On Equity -0.4208 City Wilmington Uuid bd679039-6020-3511-9086-079b47a4236e
Previous Close 3.04 First Trade Date Epoch Utc 1 B Book Value 3.25
Beta -0.3360 Total Debt 58000 Volume 133182
Price To Book 0.9896 Fifty Two Week Low 2.35 Total Cash Per Share 2.88
Shares Short Previous Month Date 1 B Max Age 86400 Sand P52 Week Change 0.3133
Net Income To Common -69122000 Ask 3.25 Short Percent Of Float 0.1015
Implied Shares Outstanding 67 M Last Fiscal Year End 1 B Trailing Peg Ratio None
Average Daily Volume10 Day 295520 Average Volume10days 295520 Total Cash 193 M
Next Fiscal Year End 1 B Held Percent Insiders 0.1036 Trailing PE 0.0000
Date Short Interest 1 B Most Recent Quarter 1 B Regular Market Previous Close 3.04
Target Low Price 0.0000 Gmt Off Set Milliseconds -18000000 Fifty Day Average 4.54
Open 3.08 Free Cashflow -39248000 State DE
Dividend Yield 0.00 % Return On Assets -0.2744 Time Zone Short Name EST
Trailing Eps -1.70 Day Low 3.02 Address1 PMB #117, 2801 Centerville Road
Shares Outstanding 67 M Price Hint 4 Target High Price 0.0000
Website https://eliemtx.com 52 Week Change 0.2578 Average Volume 570582
Recommendation Key none Forward Eps 0.0000 Quick Ratio 5677.50 %
Is_sp_500 False Regular Market Day High 3.22 Profit Margins 0.00 %
Debt To Equity 0.0270 Fifty Two Week High 11.55 Day High 3.22
Shares Short 4 M Regular Market Open 3.08 Industry Key biotechnology
Bid 3.18 Earnings Growth 0.00 % Revenue Growth 0.00 %
Shares Percent Shares Out 0.0735 Operating Cashflow -10988000 Currency USD
Time Zone Full Name America/New_York Market Cap 216 M Is_nasdaq_100 False
Zip 19808-1609 Quote Type EQUITY Industry Biotechnology
Long Name Climb Bio Inc Regular Market Day Low 3.02 Held Percent Institutions 0.8445
Current Price 3.22 Address2 1st Floor Financial Currency USD
Current Ratio 57.73 Industry Disp Biotechnology Country United States
Float Shares 26 M Two Hundred Day Average 5.66 Enterprise Value 23 M
Forward PE 0.0000 Regular Market Volume 133182 Exchange NGM
Go to Yahoo Finance Go to Seeking Alpha 
Climb Bio, Inc., a biotechnology company, focuses on developing therapies for autoimmune-driven inflammatory diseases.

It develops budoprutug, an anti-CD19 monoclonal antibody for various autoimmune diseases, including systemic lupus erythematosus and lupus nephritis, immune thrombocytopenia, and membranous nephropathy.

The company was formerly known as Eliem Therapeutics, Inc. and changed its name to Climb Bio, Inc. in October 2024.

Climb Bio, Inc. was incorporated in 2018 and is headquartered in Wilmington, Delaware.